News & Articles

The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted

The seamless integration of AI into digital pathology workflows aims to improve quality and efficiency of cancer diagnosis

An additional high-throughput Illumina NovaSeq 6000 is installed in Amsterdam as a result of increased demand for Macrogen’s sequencing services

Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimization software

Innovation and growth remain a priority to support customers and COVID-19 initiatives

Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month

Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing

The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods

Bees are in decline because of intensive farming, pesticide prevalence and climate change – but human welfare depends on them

Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences

In this guest article by RayBiotech Life, learn how to easily obtain IHC positive controls for different pathologies without the need for patient samples

The independent study is being led by Southampton University Health Sciences